In Q4'25, META's total operating expenses reached $24.24B USD, with R&D expenses at a record $17.14B USD and SG&A expenses at $7.11B USD, reflecting intensified investments in innovation and administrative functions amid robust growth. Over the period from Q1'23 to Q4'25, R&D expenses exhibited a strong upward trajectory, rising from $9.38B USD to $17.14B USD with notable acceleration in the latter half, particularly a 13% quarter-over-quarter increase in Q3'25 to $15.14B USD, indicating sustained focus on research and development. In contrast, SG&A expenses displayed volatility, fluctuating between $4B USD and $7.32B USD before stabilizing and climbing to $7.11B USD in Q4'25, contributing to overall operating expenses growing approximately 2.5 times from $15.31B USD to $24.24B USD, underscoring META's expanding operational scale.